Scholars@Duke
Renato Delascio Lopes

Renato Delascio Lopes

Professor of Medicine
Medicine, Cardiology
renato.lopes@duke.edu
Duke Box 3850, Durham, NC 27715
300 W. Morgan St., Durham, NC 27701

Overview

Atrial Fibrillation
Antithrombotic Therapy in patients with Acute Coronary Syndromes
Elderly patients with Heart Disease
Biomarkers in Acute Coronary Syndromes and Atrial Fibrillation
Thrombosis and Anticoagulation and novel antithrombotic agents
Metabolomics in Cardiovascular Medicine

Current Duke Appointments & Affiliations

Professor of Medicine · 2021 - Present Medicine, Cardiology, Medicine
Member in the Duke Clinical Research Institute · 2009 - Present Duke Clinical Research Institute, Institutes and Centers

Recent News Items

Published November 16, 2023
Which Duke Scholars Made the Most Cited List?
Published March 18, 2019
When Less is More: Some Heart Patients Should Skip Aspirin as Part of Treatment
Published March 15, 2019
Your Treatment for Heart Disease May Not Be Backed by Good Science

View All News Items

Recent Scholarly Works

Recurrent myocardial infarction identified by centralized troponin review: Insights from the MINT trial.

Journal article Am Heart J · December 2026 BACKGROUND: The utility of routine troponin testing to identify recurrent myocardial infarction (MI) after an incident MI is unclear. We assessed the incidence and prognosis of recurrent MIs identified from centralized troponin review in patients from the ... Full text Link to item Cite

Registry of atrial fibrillation in Latin America: Primary results of the LACROSS study.

Journal article Am Heart J · November 2026 BACKGROUND: Atrial fibrillation (AF) affects more than 1% of the adult population but there is limited data of these patients in Latin America. A registry was conducted including patients with AF in four countries in Latin America. METHODS: LACROSS was a m ... Full text Link to item Cite

Antiphospholipid antibodies and cardiovascular thrombosis.

Journal article Nat Rev Cardiol · October 2026 Antiphospholipid antibodies (aPL) are directed against phospholipids and phospholipid-binding proteins. Laboratory assays used to detect aPL include serological tests for aPL against β2-glycoprotein 1, cardiolipin and other molecules, as well as functional ... Full text Link to item Cite
View All Scholarly Works

Recent Grants

MK7962-041

Clinical TrialPrincipal Investigator · Awarded by Merck Sharp & Dohme LLC · 2026 - 2030

Protocol CS12_CEC

Clinical TrialPrincipal Investigator · Awarded by Ionis Pharmaceuticals Inc · 2025 - 2029

View All Grants

Education

Duke University, School of Medicine · 2009 M.H.S.
Paulista Medical School, University of Sao Paulo (Brazil) · 2006 Ph.D.
University of Santo Amaro (Brazil) · 2001 M.D.